Publications by authors named "Alla Skapenko"

Claim this Profile
A
Adverse events of SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease during repeated vaccination: An observational cohort study.
Liam Huppke, Christina Gebhardt, Lea Grümme, Julia Lichtnekert, Delila Singh, Alla Skapenko

Rheumatol Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study.
Marion Subklewe, Giulia Magno, Christina Gebhardt, Veit Bücklein, Franziska Szelinski, Alla Skapenko

Eur J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Back Pain and Psoriasis: Expecting Spondyloarthritis, Discovering Lymphoma.
Fabian T H Ullrich, Nina Hesse, Denis Poddubnyy, Alla Skapenko, Hendrik Schulze-Koops

Cureus· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colitis induced by IL-17A-inhibitors.
Lea Grümme, Sophia Dombret, Thomas Knösel, Alla Skapenko, Hendrik Schulze-Koops

Clin J Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous abortion as differential diagnosis of intermittent glomerular proteinuria in inactive systemic lupus erythematosus.
Fabian T H Ullrich, Alla Skapenko, Hendrik Schulze-Koops

Clin Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccination in individuals with inflammatory rheumatic diseases.
Alla Skapenko, Hendrik Schulze-Koops

Nat Rev Rheumatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare side effect of methotrexate therapy: drug-induced osteopathy with multiple fractures of the lower limb.
Delila Singh, Nina Hesse, Alla Skapenko, Hendrik Schulze-Koops

RMD Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'.
Hendrik Schulze-Koops, Alla Skapenko, Andreas Krause, Klaus Krueger, Hanns-Martin Lorenz

Ann Rheum Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive arthritis after SARS-CoV-2 infection.
Sophia Dombret, Alla Skapenko, Hendrik Schulze-Koops

RMD Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci .
Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht Vallbracht, Rebecca Hasseli, Alla Skapenko

Ann Rheum Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32.
Peter Lehmkuhl, Magdalena Gentz, Andres Caballero Garcia de Otezya, Bodo Grimbacher, Hendrik Schulze-Koops, Alla Skapenko

Cell Mol Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab.
Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht, Rebecca Hasseli, Alla Skapenko

Ann Rheum Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Hendrik Schulze-Koops, Christof Specker, Alla Skapenko

RMD Open· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered T cell plasticity favours Th17 cells in early arthritis.
Jan Leipe, Fausto Pirronello, Hendrik Schulze-Koops, Alla Skapenko

Rheumatology (Oxford)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased plasticity of non-classic Th1 cells toward the Th17 phenotype.
Jan Leipe, Fausto Pirronello, Antonia Klose, Hendrik Schulze-Koops, Alla Skapenko

Mod Rheumatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints.
Jonas Feist, Antoine Murray, Alla Skapenko, Hendrik Schulze-Koops

Arthritis Rheumatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate- or methotrexate-treated rheumatoid arthritis patients in OPTIMA.
Alla Skapenko, Josef S Smolen, Arthur Kavanaugh, Vipin Arora, Hartmut Kupper

Clin Exp Rheumatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases.
Ariane Hammitzsch, Liye Chen, Jelle de Wit, M Hussein Al-Mossawi, Anna Ridley, Alla Skapenko

Sci Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy.
Jan Leipe, Lisa A Christ, Andreas P Arnoldi, Erik Mille, Frank Berger, Alla Skapenko

RMD Open· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Epigenetic Regulation of the Interleukin-9 Gene by Chromatin Immunoprecipitation.
Alla Skapenko, Hendrik Schulze-Koops

Methods Mol Biol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary CCR2CD4 T cells are immune regulatory and attenuate lung fibrosis development.
Katrin Milger, Yingyan Yu, Eva Brudy, Martin Irmler, Alla Skapenko

Thorax· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm.
Hendrik Schulze-Koops, Alla Skapenko

Rheumatology (Oxford)· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation of an intragenic alternative promoter regulates transcription of GARP.
Sonja Haupt, Viktoria Sophie Apollonia Söntgerath, Jan Leipe, Hendrik Schulze-Koops, Alla Skapenko

Biochim Biophys Acta· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis.
Qihui Zhou, Sonja Haupt, Johannes T Kreuzer, Ariane Hammitzsch, Fabian Proft, Alla Skapenko

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010.
Jan Leipe, Markus A Schramm, Iryna Prots, Hendrik Schulze-Koops, Alla Skapenko

Arthritis Rheumatol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis